Dela Torre, Eric B.
HRN: 23-11-75 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
05/26/2023
AMPICILLIN 1GM + SULBACTAM 500MG (VIAL)
05/26/2023
06/01/2023
IVT
1.5g
Q6
Abscess Formation
Waiting Final Action
Indication: Empiric Type of Infection: Skin & Soft TissueUnspecified Sepsis Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes